Lobular Breast Cancer: Understanding This Subtype and Its Treatment
Dr. Otto Metzger, oncologist at Dana Farber Cancer Institute, will discuss treatment for lobular breast cancer. Dr. Metzger will also talk about his research seeking to identify predictive biomarkers of sensitivity to specific agents and mechanisms of resistance to endocrine therapy. Dr. Metzger will be joined by patient advocate Lori Petitti of the Lobular Breast Cancer Alliance.
Wednesday, 1:00-2:00pm ET
May 15, 2019
This program has ended.